Ovid Therapeutics Inc. (OVID) Net margin 2020–2025
Ovid Therapeutics Inc. (OVID) net profit margin by fiscal year — reported net income divided by reported revenue.
-239.9%FY2025 · since FY2020: -642.3% → -239.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -239.9% | +4424.4 pp |
| FY2024 | -4664.3% | +8677.5 pp |
| FY2023 | -13341.8% | -9737.2 pp |
| FY2022 | -3604.7% | -3663.6 pp |
| FY2021 | 58.9% | +701.2 pp |
| FY2020 | -642.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice